Parallax Volatility Advisers’s Cytokinetics CYTK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $162K | Sell |
4,889
-33,673
| -87% | -$1.11M | ﹤0.01% | 409 |
|
2025
Q1 | $1.55M | Sell |
38,562
-4,221
| -10% | -$170K | ﹤0.01% | 236 |
|
2024
Q4 | $2.01M | Buy |
42,783
+4,323
| +11% | +$203K | ﹤0.01% | 273 |
|
2024
Q3 | $2.03M | Buy |
38,460
+7,041
| +22% | +$372K | ﹤0.01% | 252 |
|
2024
Q2 | $1.7M | Buy |
31,419
+30,150
| +2,376% | +$1.63M | ﹤0.01% | 267 |
|
2024
Q1 | $89K | Buy |
+1,269
| New | +$89K | ﹤0.01% | 465 |
|
2023
Q4 | – | Hold |
0
| – | – | – | 755 |
|
2023
Q1 | – | Sell |
-427
| Closed | -$19.6K | – | 1010 |
|
2022
Q4 | $19.6K | Buy |
427
+24
| +6% | +$1.1K | ﹤0.01% | 676 |
|
2022
Q3 | $20K | Buy |
+403
| New | +$20K | ﹤0.01% | 830 |
|
2020
Q4 | – | Sell |
-7,228
| Closed | -$156K | – | 1077 |
|
2020
Q3 | $156K | Buy |
+7,228
| New | +$156K | ﹤0.01% | 932 |
|
2018
Q1 | – | Sell |
-6,342
| Closed | -$52K | – | 1569 |
|
2017
Q4 | $52K | Buy |
+6,342
| New | +$52K | ﹤0.01% | 2085 |
|